We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Agilent Technologies to Acquire Assets of iLab Solutions

By LabMedica International staff writers
Posted on 04 Jul 2016
Agilent Technologies Inc. (Santa Clara, California, USA) will acquire most of the assets of iLab Solutions, LLC (Boston, Massachusetts, USA), including the company’s technology, intellectual property, product portfolio and employee talent. The acquisition is expected to be completed in early August, subject to local laws and regulations and customary closing conditions.

Agilent provides instruments, software, services and consumables for the entire laboratory workflow to customers in more than 100 countries, while iLab offers cloud-based solutions for core laboratory management to universities, research hospitals and independent institutes. iLab’s offerings allow customers to book time in shared facilities to bill and invoice for projects, manage studies, generate reports and business intelligence, and schedule instrument reservations across multiple projects.

“Our acquisition of iLab further expands our offerings portfolio in a space we previously did not have a presence in,” said Mark Doak, president, Agilent CrossLab Group. “iLab’s solutions are robust and scalable, allowing for expansion into large-enterprise accounts, including Pharma. With iLab’s experience and outstanding enterprise-level management solutions, we will be able to immediately deliver broader value for our customers.”

“Joining forces with Agilent is an excellent fit for us,” said Tad Fallows, chief executive officer, iLab Solutions. “It is also a tremendous opportunity for our customers, who will benefit from integration with a broad family of solutions and a range of new applications. Together, we’ll be able to further accelerate our offerings to additional markets through Agilent’s global reach and leadership in multiple market segments.”

Related Links:
Agilent Technologies
iLab Solutions

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests